Midgard Science

Labs / Assays & in vitro testing

HUB Organoids

Utrecht, Netherlands · huborganoids.nl

HUB Organoids develops patient-derived organoid models and offers drug screening, custom assay and model development, and clinical-trials-in-a-dish services. It works with drug developers and researchers in oncology, immuno-oncology, inflammatory diseases, genetic diseases, infectious diseases, toxicology, and metabolic disease. The company is based in the Netherlands and is part of the Life Science Business of Merck KGaA, Darmstadt, Germany.

They take quote requests through a form on their website with project details. Their quote form

What they offer

  • Drug screening services

    Uses patient-derived organoids to evaluate compound efficacy and toxicity and predict patient-specific responses.

  • Custom model and assay development

    Creates organoid models and bespoke assays tailored to specific diseases or therapeutic areas.

  • Clinical trials in a dish

    Provides co-clinical testing using patient-derived organoid technology to support drug development decisions.

  • PDO Screen

    Offers fast screening on a preset panel of patient-derived tumor organoids for oncology drug development.

  • HumanTox Insight

    Assesses animal-to-human translatability in preclinical toxicology research.

  • IntegriGut Screen

    Tests protective effects of compounds against epithelial damage in inflammatory disease models.

  • KRAS Inhibitor Testing Solutions

    Uses patient-derived organoids to test efficacy and study resistance mechanisms for KRAS inhibitors.

  • mCRC PDO Screening Panel

    Supports metastatic colorectal cancer drug decisions using patient-relevant organoid biology.

  • ADC Organoid Screen

    Predicts therapeutic effects of antibody-drug conjugates using patient-specific organoid models.

  • Bispecific Screening Solutions

    Uses organoid-based co-cultures to evaluate bispecific antibodies.

  • PDO Co-cultures

    Provides organoid-based immune cell co-culture systems to study tumor-immune interactions.

What they work on

Modalities
Small molecule, Antibody, Bispecific, ADC, Cell therapy, Recombinant protein
Species and models
human patient-derived organoids, adult stem cell–derived organoids, mouse intestine organoid, human intestinal epithelium organoid, PBMCs, TILs, T cells, macrophages, neutrophils, NK cells, fibroblasts
Assays and studies
drug screening, custom assay development, co-culture assays, tumor-immune interaction assays, efficacy testing, toxicity testing, predictive toxicology, resistance mechanism studies, clinical trials in a dish
Scale and capacity
Thousands of patient-derived organoids across multiple tissue types and disease indications
Therapeutic areas
Oncology, Immuno-oncology, Inflammatory diseases, Genetic diseases, Infectious diseases, Toxicology, Metabolic Disease
Type
CRO
Serves
global
Founded
2023

Similar labs. Xcellon Biologics, Aurigene Pharmaceutical Services, GemPharmatech, Kyinno Bio

Found in a contract services directory. Listing built from huborganoids.nl. Work here? Claim this listing.

HUB Organoids · Midgard Science